Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hemorrhage 13Neoplasms 7Leiomyoma 7Breast Neoplasms 6Postoperative Hemorrhage 4Hematologic Neoplasms 4Thrombocytopenia 3Myofibroma 3Meningioma 3Blood Loss, Surgical 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Seroma 2Seizures 2Prostatic Neoplasms 2Postoperative Complications 2Ovarian Neoplasms 2Menorrhagia 2Head and Neck Neoplasms 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Wrist Fractures 1Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Tranexamic Acid × Clear all
NCT01655641 2012-10-16

TMGS

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Phase 2/3 Unknown
118 enrolled
Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡